Dennis Sandler, MD
Gynecology · Oklahoma City, OKNPI 1316245715
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $545 of the $658 with a category attached, or 82.9%. 11 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 37.2% of the total.
Across 45 payments — averaging $14.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$245
- Astellas Pharma US Inc$130
- AbbVie$127
- Avion Pharmaceuticals$34
- IBSA Pharma Inc.$24
- Ascend Therapeutics US, LLC$23
- plus $74 from 5 others
What the payments were for
- Food & beverage$54583%
- Education$11217%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 18 | $245 |
| Astellas Pharma US Inc | 3 | $130 |
| AbbVie | 14 | $127 |
| Avion Pharmaceuticals | 2 | $34 |
| IBSA Pharma Inc. | 1 | $24 |
| Ascend Therapeutics US, LLC | 2 | $23 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Therapeuticsmd, Inc. | 1 | $16 |
| Exact Sciences | 1 | $13 |
| Millicent US Inc | 1 | $13 |
| Antares Pharma, Inc. | 1 | $13 |
How this compares
Too few gynecology providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 78 | $4,138 |
| ProgesteroneProgesterone, Micronized | 108 | $3,380 |
| Liothyronine Sodium | 55 | $2,841 |
| DottiEstradiol | 21 | $2,378 |
| Estradiol (Twice Weekly)Estradiol | 22 | $2,049 |
| Levothyroxine Sodium | 146 | $1,597 |
| Spironolactone | 43 | $1,238 |
| ValacyclovirValacyclovir Hcl | 21 | $1,221 |
| Estradiol (Once Weekly)Estradiol | 14 | $837 |
| Testosterone Cypionate | 13 | $554 |
| Gabapentin | 12 | $461 |
| Fluoxetine Hcl | 21 | $400 |
| Montelukast Sodium | 20 | $385 |
| Topiramate | 35 | $383 |
| SynthroidLevothyroxine Sodium | 16 | $327 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $127 | $32716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few gynecology providers in Oklahomaon file to place this against a meaningful peer group, so we don't.
Other gynecology in Oklahoma City
- Kerri AnthonyOklahoma City$5K
- Royice EverettOklahoma City$332
- Pablo PinzonOklahoma City$198
- Corey BabbTulsa$169K
- Deanna WrightTahlequah$1K
- Natalie JohnsonLawton$779
- Franklin BarnettMidwest City$104
- Michelle McElroyJenks$30
- Richard PolkTulsa$21
- Rebecca DeatonTulsa$16
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.